A carregar...
Improvement of tuberous sclerosis complex skin tumors during long-term treatment with oral sirolimus
BACKGROUND: Oral mechanistic target of rapamycin (mTOR) inhibitors have been shown to reduce visceral tumor volume in tuberous sclerosis complex (TSC) patients. OBJECTIVE: To evaluate the cutaneous response to oral sirolimus in TSC patients with an indication for systemic treatment, including long-t...
Na minha lista:
| Publicado no: | J Am Acad Dermatol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609596/ https://ncbi.nlm.nih.gov/pubmed/26365597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2015.07.018 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|